Medical articles today

/* 728x15, */

Atrial Fibrillation Treatment Using Specialized Catheter Results In Better Outcomes Compared To Drug Therapy

Use of catheter ablation, in which radiofrequency energy is emitted from a catheter to eliminate the source of an irregular heartbeat, resulted in significantly better outcomes in patients with paroxysmal atrial fibrillation (intermittent cardiac rhythm disturbance) who had not responded previously to antiarrhythmic drug therapy, according to a study in the January 27 issue of JAMA. Atrial fibrillation (AF) represents an important public health problem, with patients having an increased long-term risk of stroke, heart failure and all-cause death. Although antiarrhythmic drugs are generally used as first-line therapy to treat patients with AF, they are associated with cumulative adverse effects over time and their effectiveness remains inconsistent, according to background information in the article.

Cord Blood-Derived CD133 Cells Improve Cardiac Function After Myocardial Infarction

Researchers at the Pontif├ cia Universidade Catolica do Parana and Instituto Carlos Chagas have evaluated the therapeutic potential of purified and expanded CD133+ cells human umbilical cord blood (HUCB)-derived in treating myocardial infarction by intramyocardially injecting them into a rat model. Patients who have high cardiovascular risks have fewer endothelial progenitor cells (EPCs) and their EPCs exhibit greater in vitro senescence. HUCB-derived EPCs could be an alternative to rescue impaired stem cell function in the sick and elderly. The results, which appear in the January 2010 issue of Experimental Biology and Medicine, show that expanded cells ex vivo exhibited increased expression of mature endothelial cells markers and formed tubule-like structures in vitro.

/* 468x60, */

Flirty Girl Fitness - Fast and Fun Workout For Women

Women are always looking for the next best thing in working out. Something that will give them the results they are looking for and to lose weight. Flirty Girl Fitness is a new and fun exercise routine that women will love. Being able to work out and have fun while doing it. The DVD'S included in this Flirty Girl Fitness workout plan are 2 sets. 1 that is the Teaser collection and 1 that is the Pole collection. The workouts are all done with either a simple kitchen chair a feather boa or a pole. Each video will walk you through from beginning to end. If you like to dance booty beat.This will be a great DVD. It is a fast paced workout with lots of dance moves inspired by music videos.

Happy Valentines Month - A Few Tips For Your Heart to Have a Happy Valentines Month!

Happy Valentines Day! In February start to think of Hearts, Hearts filled with chocolate, Jewelry or other goodies for our sweethearts! However, realize and appreciate a different Heart - A Heart with a Lasting Difference! With the interest of health and fitness on the rise, not only in the country but throughout the world, we often forget about our bodies heart. The following are a few interesting facts about your heart and what it does 24 hours a day, and 365 days a year. - If your Heart beats 72 times every minute, by the time you are 65 years old, your heart will have beaten about 2.5 billion times. - If you are 25 pounds overweight, you have nearly 5000 extra MILES of blood vessels through which you heart must pump blood.

Aerobic Exercise or Cardio - What is the Ideal Duration?

The ideal duration of aerobic exercise(cardio) is different for different circumstances and depends on parameters as: - Frequency. How often is it done? - Intensity. At what percentage of our maximum heart rate? - Our objectives. Do we aim for maximum fat loss, increased aerobic or anaerobic capacity? Maybe something else? - The kind of the workout. Purely aerobic or a combination with weight training? - The time we have at our disposal. - Our fitness level. General advice on the duration of aerobic exercise(cardio). 1. Avoid long, boring, low intensity aerobic workouts because your gains will be minimal and disproportional to your invested time.

/* 468x60, */

Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial For Treatment Of Recurrent Venous Thromboembolism

Daiichi Sankyo Company, Limited (TSE: 4568), announced that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe┬ koo┬ sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE). It is estimated that more than 900, 000 fatal and non-fatal VTE events occur in the U.S. annually, and approximately 300, 000 deaths are related to VTE per year.(i) In Europe, VTE affects more than 750, 000 people in six major European countries (France, Germany, Italy, Spain, Sweden, UK) annually, and approximately 370, 000 deaths are related to VTE per year in these countries.

Rocket: [100]
/* 160x600, */
Medical articles today © Padayatra Dmitriy
Designer Dimitrov Dmytriy